Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Ieper

22 clinical trials in Ieper, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ieper at a glance
22
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

22 trials in Ieper

Open in trial search
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Flecainide Acetate
  • Sponsor:UZ Leuven
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:LY3841136 SODIUM
  • Sponsor:Eli Lilly & Co.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

IgA nephropathy

Recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Codeine Phosphate
  • Sponsor:Biogen Idec Research Limited
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:St Antonius Hospital
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Semaglutide
  • Sponsor:UZ Leuven
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
  • Sponsor:AstraZeneca AB
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Ieper

What the registry says about research in the country

01 Infectious Disease Prevention

Research focusing on developing and evaluating vaccines against influenza and respiratory syncytial virus in various age groups. Multiple trials are investigating immune responses and safety profiles in both younger and older adults.

  • Influenza vaccine studies in adults 60+ years
  • RSV vaccine trials for elderly population
  • UTI vaccine development

Advanced clinical research aims to enhance protection against common respiratory infections and urinary tract pathogens.

02 Kidney Disease Management

Comprehensive studies evaluating innovative treatments for chronic kidney disease (CKD), particularly in patients with concurrent conditions like hypertension and diabetes.

  • Combined therapy approaches
  • Novel drug evaluations
  • Albumin reduction strategies

Multiple trials are exploring combination therapies and new compounds to improve outcomes in CKD patients.

03 Cardiovascular and Metabolic Disorders

Innovative research addressing cardiovascular conditions and metabolic disorders, including studies on atrial fibrillation and diabetes prevention.

  • Post-gestational diabetes interventions
  • Atherosclerotic disease in ESKD
  • Antiplatelet therapy optimization

Trials focus on both preventive measures and treatment strategies for complex cardiovascular conditions.

04 Oncology Research

Advanced studies in cancer treatment, particularly focusing on mantle cell lymphoma and endometrial cancer therapies.

  • Lymphoma combination treatments
  • Endometrial cancer maintenance therapy
  • Novel therapeutic approaches

Research aims to improve treatment outcomes through innovative drug combinations and maintenance strategies.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.